OXFORD, England, Oct. 17, 2024 /PRNewswire/ — n² Group, the transformative computing technology investment company, announces the acquisition of high-performance computing (HPC) and AI specialists, X-ISS. The addition of X-ISS expands the Group’s portfolio– joining NAG, VSNi, BioTeam and STAC—as it accelerates advancements in technology and computation, underpinned by innovation, technical excellence, and a focus on long-term growth.

n² Group invests selectively in technical computing companies with deep business impact in a variety of sectors, providing operational support and a collaborative approach to innovation and business transformation. The addition of X-ISS will further strengthen the Group’s already strong HPC/AI credentials, with NAG, STAC and BioTeam already adding to this space. 

X-ISS is a pioneer in Managed Services specifically designed for HPC/AI. With their in-depth understanding of hardware and software complexities within HPC and AI, they deliver highly impactful end-to-end services to clients through the integration, optimization and management of HPC/AI systems. The integration of X-ISS into n² Group aligns with the Group vision of improving the accessibility, quality and robustness of computing solutions to enable greater productivity in industry. 

X-ISS will operate as an autonomous business within the n² Group, maintaining its brand, identity and ethos. n² Group’s status as an independent, member-backed organisation with no external financial stakeholders allows X-ISS to continue providing impartial advice based on the technology needs and challenges of its clients. Inter-group synergies will enable greater innovation and collaboration, advancing the Group’s position and long-term HPC/AI market impact. 

“X-ISS strengthens the n² community in the strategically important area of HPC/AI”, said Adrian Scales, Snr Director of Investments and Partnerships at n² Group. “As a respected boutique HPC service provider, X-ISS is helping clients navigate an increasingly complex landscape in terms of technologies and software integrations with AI and analytics. The acquisition strongly complements the Group’s existing HPC professional services capability, and we are delighted to have them on board.”

“This is an important milestone for X-ISS.”, said Deepak Khosla, CEO X-ISS, “The partnership with n² Group will enable us to enhance our flagship ManagedHPC solution by leveraging n²‘s complementary services and product developments, allowing us to deliver even greater value to our customers. As businesses face increasing challenges with complex technologies like AI and cloud computing, we’re now better equipped to support them with the same quality, passion, and partnership that defines X-ISS. I am excited about the opportunities this can bring for current and future X-ISS customers.”

About n² Group  

At n² Group we are transforming computing and technology investment with a radical new approach. Our businesses are all established, purpose-driven market-leaders in computing products or services. We stimulate long-term sustainable growth through group-level support in strategy, business development, innovation, and operations. With no shareholders or external financial interests, we reinvest all profits back into the group or to the community, reinforcing our commitment to positive social impact through technological advancements.    

n² Group companies are at the forefront of computing and IT infrastructure, helping clients in various sectors to be more productive, innovative or reduce risk through advanced software and services. Rapidly expanding in high-performance computing, artificial intelligence, and scientific computing, our businesses maintain their unique brands and identities, but benefit from the expanded network available through the group.   

n² Group Companies  

Advertisement

•  BioTeam: Scientific computing consultancy integrating technologies, data, and cultures to accelerate science. 

•  NAG: Advanced products and services in algorithms, optimization, high-performance computing and AI. 

•  STAC: Independent financial services technology research and community events. 

•  VSNi: Proven statistical solutions and data expertise driving innovation and success.  

•  X-ISS: Industry leading management and analytics solutions for HPC/AI systems.

For more detailed information and the latest updates, visit n2 Group. 

Logo – https://mma.prnewswire.com/media/2271328/n2_Group_Logo.jpg
Logo –  https://mma.prnewswire.com/media/2533549/XISS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/n2-group-advances-hpcai-portfolio-by-acquiring-managed-services-company-x-iss-302279433.html

SAN ANTONIO, Oct. 17, 2024 /PRNewswire/ — AIMed24, the premier event for artificial intelligence and healthcare innovation, is excited to announce its strategic partnership with Frost & Sullivan. This collaboration will further enhance AIMed24’s mission to advance healthcare with cutting-edge AI technologies. The conference will take place from November 17-19, 2024, at the Caribe Royale Orlando.

With over 60 years of supporting client growth, Frost & Sullivan has established itself as a leader in growth strategy and innovation through its unique Ecosystem of Content, Community, and Coaching. Frost’s Growth Pipeline as a Service (GPaaS) empowers companies, governments, and investors to maximize their economic potential while navigating emerging trends and pursuing sustainable growth. This partnership aligns perfectly with AIMed24’s focus on future-proofing healthcare through innovation.

Dr. Anthony Chang, founder of AIMed and Chief Intelligence and Innovations Officer at Children’s Hospital of Orange County, said, “Partnering with Frost & Sullivan brings immense value to AIMed24. Their expertise in fostering growth and innovation across industries, including healthcare, complements our mission to lead the conversation on AI’s transformative impact on patient care. Together, we’re shaping the future of medicine with pioneering ideas and real-world solutions.”

Greg Caressi, Senior Vice President of Global Client Services at Frost & Sullivan, shared his enthusiasm, stating, “We are thrilled to partner with AIMed24, a conference that has consistently brought together the brightest minds in AI and healthcare. This partnership aligns with our commitment to creating opportunities for sustainable growth and innovation, and our focus on AI in healthcare and life sciences applications. We look forward to contributing to the exchange of knowledge that will inspire the next wave of healthcare advancements.”

AI Med, a leading event that brings together experts at the intersection of artificial intelligence and healthcare, will serve as a platform for Greg Caressi to share his deep expertise in digital health transformation and AI-driven healthcare innovations. As a recognized thought leader in healthcare technology and innovation, Greg has spent decades analyzing emerging trends and fostering strategic initiatives that enhance data transformation and utilization of data to drive health outcomes.

AIMed24 is the must-attend conference for healthcare professionals, AI innovators, and technology leaders. With strategic partnerships like Frost & Sullivan, this year’s event promises to deliver an immersive experience, featuring groundbreaking keynote speakers, hands-on workshops, and unparalleled networking opportunities. The collaboration highlights AIMed’s global impact, with representation from all five continents and over 50 countries throughout its history. Attendees will have the opportunity to learn from industry experts and gain insights into AI’s role in shaping the future of healthcare.

Why This Partnership Matters: AIMed24 is committed to building long-term partnerships with key organizations that share its vision of improving healthcare through AI. Frost & Sullivan’s expertise in identifying growth opportunities and their forward-looking approach to industry trends makes them an ideal partner. Together, AIMed24 and Frost & Sullivan will deliver a unique, high-value experience for attendees, ensuring they leave equipped with actionable strategies and insights to drive AI innovation in healthcare.

Scholarships and Global Representation: AIMed24 is proud to continue its tradition of supporting clinicians and students from around the world through special scholarships. This initiative ensures that financial barriers do not prevent the brightest minds from participating in this world-class event.

Register Today: Don’t miss out on AIMed24! To learn more about the event and secure your tickets, visit www.aimed.events.

About Frost & Sullivan
For over six decades, Frost & Sullivan has guided the world’s top companies toward transformational growth journeys that result in a stream of innovative growth opportunities. Frost’s Growth Pipeline as a Service (GPaaS) value proposition allows customers to maximize their economic potential, navigate emerging megatrends, and shape a future based on sustainable growth. Learn more.

Advertisement

About AIMed24
AIMed24 is where AI and medicine’s brightest minds converge to shape the future of healthcare. Join us at the Caribe Royale Orlando from November 17-19 for groundbreaking keynotes, hands-on workshops, and exceptional networking opportunities with industry leaders.

Founded by Dr. Anthony Chang, AIMed is a clinician-led community advancing AI in health. AIMed24 will showcase impactful smart healthcare solutions, facilitate connections with AI trailblazers, and engage with top institutions and innovators.

Be at the forefront of healthcare innovation. Learn more.

View original content:https://www.prnewswire.co.uk/news-releases/press-announcement-aimed24-announces-strategic-partnership-with-frost–sullivan-302279447.html

• Exponential Science, a global non-profit foundation supported by leading technology companies like Hedera, drives innovation in emerging technologies to tackle complex challenges and deliver groundbreaking solutions.
• With global operations, the Foundation fosters open collaboration and co-creation between academia, industry, government, the open-source community, and startups.
• The launch details were announced on stage during the exclusive 10th annual P2P Financial Systems International Workshop, in Dubai.

DUBAI, UAE, Oct. 17, 2024 /PRNewswire/ — Dr. Paolo Tasca, Founder and Chairman, and Nikhil Vadgama, Founder and Director, have launched Exponential Science, a non-profit foundation, created to build on their legacy of leadership in the blockchain space through the DLT Science Foundation.

Exponential Science was established to address the growing interdependencies among emerging digital technologies and deep tech. It will focus on the complementarity of blockchain with other cutting-edge technologies, including artificial intelligence, quantum computing, AR/VR and other deep tech.

Exponential Science leverages the expertise of Dr. Tasca and Nikhil Vadgama. Tasca is a renowned professor and economist with an extensive background in distributed systems and digital innovation. He has advised organizations such as the United Nations and several central banks on CBDC and Fintech. He co-founded the UCL Centre for Blockchain Technologies and also co-founded several top Web3 companies. Prof. Vadgama, has extensive experience in fintech, having launched innovative new businesses in multiple jurisdictions and worked with and advised a number of leading stakeholders, from industry participants to government officials. He is also an award-winning educator in the field of emerging technologies.

Both have witnessed the convergence of multiple emerging digital technologies, highlighting the need for interdisciplinary approaches to tackle complex societal and technological challenges. To address this, Exponential Science fosters open collaboration and co-creation among academia, industries, and government stakeholders. It also runs its cutting-edge science research department, comprised of renowned professors and visionary thinkers.

The team is made up of international academic and research experts from diverse fields and disciplines who are working on various initiatives, including the new MiCA Crypto Alliance, which helps blockchain and crypto businesses meet the EU’s incoming regulatory requirements. Other key projects include work with the UK CBT, the national research hub that drives the UK agenda for blockchain, and DLT Earth, an initiative seeking to advance climate research, sustainable finance, and ESG reporting methodologies.

The foundation’s upcoming plans include a range of initiatives aimed at expanding scientific impact and fostering collaboration across sectors.  Research and spinoff initiatives will target specific challenges, enabling the exploration of niche areas of innovation and accelerating progress in critical fields. Complementing these efforts, a robust content and event strategy will be implemented, creating a dynamic platform for knowledge sharing and collaboration.

Exponential Science is backed by Hedera, a high-performance, secure, and sustainable public DLT network governed by the world’s leading institutions. This backing enables Exponential Science to leverage extensive resources and expertise, further empowering its mission to drive interdisciplinary collaboration and deliver impactful solutions to societal challenges.

Dr Tasca said: “Our vision has always been about driving groundbreaking research and fostering collaboration across technological fields. With the launch of Exponential Science, we are expanding that vision to embrace a wider range of emerging technologies that are reshaping the digital landscape. We will navigate this fusion using a multi-disciplinary approach to explore how these technologies can work together to create solutions that address today’s most pressing challenges.”

Professor Vadgama commented: “Exponential Science represents our commitment to exploring and addressing the interconnectedness of today’s technological landscape. By broadening our focus, we can leverage the combined power of multiple technologies to deliver transformative outcomes. Our objective is to empower open source communities and industries to thrive in this rapidly evolving landscape.”

About Exponential Science

Exponential Science is a not-for-profit foundation driven to advance research, education, and innovation across emerging digital technologies and deep tech. With a mission to explore the convergence of blockchain, Artificial Intelligence (AI), the Internet of Things (IoT), and other transformative technologies, Exponential Science drives interdisciplinary collaboration to deliver impactful solutions to challenges faced by society. It brings together stakeholders from academic institutions, regulators, and diverse industries to drive innovative research and collaboration. Exponential Science is committed to fostering sustainable, transparent, and innovative developments that will shape a more advanced and interconnected future. For more information go to: www.exponentialscience.org.

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/exponential-science-launches-to-advance-the-convergence-of-blockchain-with-ai-and-other-deep-tech-302279374.html